TigerGene

TigerGene LLC is a venture capital firm that invests in early-stage technologies with high-growth trajectories across the life sciences sector. The fund's current portfolio focuses on technology platforms as well as technology-derived products and assets across the genomics, proteomics, diagnostics, drug discovery, and therapeutics spaces. At Tiger Gene, we are more than just investors – we’re collaborators and innovators, passionate about advancing breakthroughs in therapeutics and life science tool,s and diagnostics. Our mission is simple yet profound: to seek out promising technologies that address unmet needs in these vital fields and transform them into successful companies that make a significant difference in medicine. We work closely with inventors, scientists, and researchers, fostering a collaborative environment where ideas can flourish and innovations can thrive. By partnering with the most promising minds, who have created innovative technology platforms, in the industry, we ensure that our portfolio companies have the tools, business expertise, and vision needed to succeed.